Cas:7512-45-0 2-[[2-(benzylsulfonylamino)acetyl]amino]acetic acid manufacturer & supplier

We serve Chemical Name:2-[[2-(benzylsulfonylamino)acetyl]amino]acetic acid CAS:7512-45-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-[[2-(benzylsulfonylamino)acetyl]amino]acetic acid

Chemical Name:2-[[2-(benzylsulfonylamino)acetyl]amino]acetic acid
CAS.NO:7512-45-0
Synonyms:N-(N-phenylmethanesulfonyl-glycyl)-glycine;N-(N-Phenylmethansulfonyl-glycyl)-glycin;({[(benzylsulfonyl)amino]acetyl}amino)acetic acid
Molecular Formula:C11H14N2O5S
Molecular Weight:286.30400
HS Code:2935009090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:120.95000
Exact Mass:286.06200
LogP:1.16940

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like N-(N-phenylmethanesulfonyl-glycyl)-glycine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,({[(benzylsulfonyl)amino]acetyl}amino)acetic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,({[(benzylsulfonyl)amino]acetyl}amino)acetic acid Use and application,N-(N-phenylmethanesulfonyl-glycyl)-glycine technical grade,usp/ep/jp grade.


Related News: Domestic API companies cooperate with major international companies through commissioned processing, patent transfer, and joint venture production. 2-[[2-(benzylsulfonylamino)acetyl]amino]acetic acid manufacturer Physiologically relevant interactions with test molecules or protein ligands can be identified with high sensitivity and specificity. 2-[[2-(benzylsulfonylamino)acetyl]amino]acetic acid supplier Domestic API companies cooperate with major international companies through commissioned processing, patent transfer, and joint venture production. 2-[[2-(benzylsulfonylamino)acetyl]amino]acetic acid vendor Lilly spokesperson Kathryn Beiser and a Justice Department spokesperson declined to comment. Clark did not respond to a request for comment. A Covington spokesperson did not respond to a request for comment nor to a request for a copy of the firm’s report. 2-[[2-(benzylsulfonylamino)acetyl]amino]acetic acid factory Since the listing of high-barrier generic drugs involves quickly bypassing or challenging process patents of original research products within a short period of time, API companies play an important role in the process of marketing and sales of generic drugs.